Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Varona, L. Blanco, Itxaro Pérez, Javier Gil, J. Irazusta, José López, M. Candenas, Francisco Pinto, G. Larrinaga (2010)
Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependentBMC Cancer, 10
E. Herrmann, O. Brinkmann, M. Bode, S. Bierer, T. Köpke, M. Bögemann, L. Hertle, C. Wülfing (2007)
Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with interleukin 2, interferon alpha and 5-fluorouracil.European urology, 51 6
N. Mikami, H. Matsushita, Tetsuya Kato, R. Kawasaki, Taichi Sawazaki, T. Kishimoto, Y. Ogitani, Keiko Watanabe, Yayoi Miyagi, K. Sueda, S. Fukada, Hiroshi Yamamoto, K. Tsujikawa (2011)
Calcitonin Gene-Related Peptide Is an Important Regulator of Cutaneous Immunity: Effect on Dendritic Cell and T Cell FunctionsThe Journal of Immunology, 186
Adalberto Merighi, O. Ytm (2011)
Neuropeptides
C. Bonifant, Jung‐Sik Kim, T. Waldman (2007)
NHERFs, NEP, MAGUKs, and more: Interactions that regulate PTENJournal of Cellular Biochemistry, 102
D. Bellinger, D. Lorton, S. Brouxhon, S. Felten, D. Felten (1996)
The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation.Advances in neuroimmunology, 6 1
N. Erin, G. Clawson (2004)
Parameters affecting substance P measurement in heart, lung, and skin.BioTechniques, 37 2
N. Erin, Özkan Ulusoy (2009)
Differentiation of neuronal from non-neuronal Substance PRegulatory Peptides, 152
L. McLatchie, N. Fraser, M. Main, A. Wise, Jason Brown, N. Thompson, Roberto Solari, Melanie Lee, S. Foord (1998)
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptorNature, 393
P. Gourlet, A. Vandermeers, P. Robberecht, M. Deschodt-Lanckman (1997)
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11.Biochemical pharmacology, 54 4
G. Kovacs, M. Akhtar, B. Beckwith, P. Bugert, C. Cooper, B. Delahunt, J. Eble, S. Fleming, B. Ljungberg, L. Medeiros, H. Moch, V. Reuter, E. Ritz, G. Roos, D. Schmidt, J. Srigley, S. Störkel, E. Berg, B. Zbar (1997)
The Heidelberg classification of renal cell tumoursThe Journal of Pathology, 183
Dan Huang, Yan Ding, Ming Zhou, B. Rini, D. Petillo, C. Qian, R. Kahnoski, P. Futreal, K. Furge, B. Teh (2010)
Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma.Cancer research, 70 3
N. Erin, Ş. Kale, Gamze TanriÖver, S. Köksoy, Özlem Duymuş, A. Korcum (2013)
Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinomaBreast Cancer Research and Treatment, 139
S. Smalley, P. Barrow, N. Foster (2009)
Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory diseaseClinical & Experimental Immunology, 157
AA Slater, M Alokail, D Gentle, M Yao, G Kovacs, ER Maher, F Latif (2013)
DNA mmethylation pprofiling ddistinguishes hhistological ssubtypes of rrenal ccell ccarcinomaEpigenetics, 8
J. Godlewski, J. Kaleczyc (2010)
Somatostatin, substance P and calcitonin gene-related peptide-positive intramural nerve structures of the human large intestine affected by carcinoma.Folia histochemica et cytobiologica, 48 3
R. Mentlein, T. Roos (1996)
Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cellsPeptides, 17
A. Slater, M. Alokail, D. Gentle, M. Yao, G. Kovacs, E. Maher, F. Latif (2013)
DNA methylation profiling distinguishes histological subtypes of renal cell carcinomaEpigenetics, 8
A. Harmar, A. Arimura, I. Gozes, L. Journot, M. Laburthe, J. Pisegna, S. Rawlings, P. Robberecht, S. Said, S. Sreedharan, S. Wank, J. Waschek (1998)
International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.Pharmacological reviews, 50 2
B. Göhring, H. Holzhausen, A. Meye, H. Heynemann, U. Rebmann, J. Langner, D. Riemann (1998)
Endopeptidase 24.11/CD10 is down-regulated in renal cell cancer.International journal of molecular medicine, 2 4
G. Larrinaga, L. Blanco, Begoña Sanz, Itxaro Pérez, Javier Gil, M. Unda, Leire Andrés, L. Casis, J. López (2012)
The impact of peptidase activity on clear cell renal cell carcinoma survival.American journal of physiology. Renal physiology, 303 12
R. Skidgel, E. Erdös (2004)
Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studiesPeptides, 25
N. Auphan-Anezin, G. Verdeil, Magali Grange, S. Soudja, Maria Wehbe, M. Buferne, A. Mas, A. Schmitt-Verhulst (2013)
Immunosuppression in inflammatory melanoma: can it be resisted by adoptively transferred T cells?Pigment Cell & Melanoma Research, 26
(2006)
PAC1 receptor: emerging target for septic shock therapy
E. Vacas, A. Fernández-Martínez, A. Bajo, M. Sánchez-chapado, A. Schally, J. Prieto, M. Carmena (2012)
Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation.Biochimica et biophysica acta, 1823 10
P. Fox, M. Hudson, Chris Brown, S. Lord, V. Gebski, P. Souza, C. Lee (2013)
Markers of systemic inflammation predict survival in patients with advanced renal cell cancerBritish Journal of Cancer, 109
M. Sumitomo, R. Shen, D. Nanus (2005)
Involvement of neutral endopeptidase in neoplastic progression.Biochimica et biophysica acta, 1751 1
J. Norvell, R. Macbride, J. Rowell (1991)
Vasoactive intestinal polypeptide nerve fibers in human and monkey (Macaca fascicularis and Macaca mulatta) kidneys.Journal of the autonomic nervous system, 32 2
E. Vacas, M. Arenas, L. Muñoz-Moreno, A. Bajo, M. Sánchez-chapado, Juan-Carlos Prieto, M. Carmena (2013)
Antitumoral effects of vasoactive intestinal peptide in human renal cell carcinoma xenografts in athymic nude mice.Cancer letters, 336 1
N. Erin, A. Korcum, Gamze TanriÖver, Ş. Kale, N. Demir, S. Köksoy (2015)
Activation of neuroimmune pathways increases therapeutic effects of radiotherapy on poorly differentiated breast carcinomaBrain, Behavior, and Immunity, 48
J. Reubi (2000)
In Vitro Evaluation of VIP/PACAP Receptors in Healthy and Diseased Human Tissues: Clinical ImplicationsAnnals of the New York Academy of Sciences, 921
N. Erin, Özlem Duymuş, Saffet Öztürk, N. Demir (2012)
Activation of vagus nerve by semapimod alters substance P levels and decreases breast cancer metastasisRegulatory Peptides, 179
N. Erin, Wei Zhao, J. Bylander, G. Chase, G. Clawson (2006)
Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cellsBreast Cancer Research and Treatment, 99
M. Delgado, D. Pozo, D. Ganea (2004)
The Significance of Vasoactive Intestinal Peptide in ImmunomodulationPharmacological Reviews, 56
N. Erin, P. Boyer, R. Bonneau, G. Clawson, D. Welch (2004)
Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart.Anticancer research, 24 2B
M. Terauchi, H. Kajiyama, K. Shibata, K. Ino, S. Mizutani, F. Kikkawa (2005)
Anti-Progressive Effect of Neutral Endopeptidase 24.11 (NEP/CD10) on Cervical Carcinoma in vitro and in vivoOncology, 69
N. Hanaoka, B. Jabri, Z. Dai, C. Ciszewski, A. Stevens, C. Yee, H. Nakakuma, T. Spies, V. Groh (2010)
NKG2D Initiates Caspase-Mediated CD3ζ Degradation and Lymphocyte Receptor Impairments Associated with Human Cancer and Autoimmune DiseaseThe Journal of Immunology, 185
Ming Zhou, A. Roma, C. Magi-Galluzzi (2005)
The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms.Clinics in laboratory medicine, 25 2
E. Vacas, L. Muñoz-Moreno, A. Fernández-Martínez, A. Bajo, M. Sánchez-chapado, J. Prieto, M. Carmena (2014)
Signalling pathways involved in antitumoral effects of VIP in human renal cell carcinoma A498 cells: VIP induction of p53 expression.The international journal of biochemistry & cell biology, 53
N. Erin, A. Podnos, G. Tanriover, Özlem Duymuş, E. Côté, I. Khatri, Reginald Gorczynski (2014)
Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory responseOncogene, 34
Calcitonin Gene-related Peptide (CGRP), Vasoactive Intestinal Peptide (VIP) and Substance P (SP) are sensory neuropeptides which may alter cancer growth through modulation of chronic inflammation. We recently reported that SP suppresses breast cancer growth and metastasis through neuroimmune modulation. These neuropeptides are hydrolyzed by Neprilysin (NEP) to bioactive fragments. Decreased activity of NEP was reported in clear cell and chromophobe type renal cell carcinoma (RCC). It is however not known how the levels of neuropeptides hydrolyzed with NEP changes in RCC. Decrease activity of SP and CGRP containing sensory nerve endings was previously reported to increase cancer metastasis in animal models. It is however not known how peptidergic nerve endings are altered in RCC. Hence we here evaluated the levels of neuronal and non-neuronal neuropeptides and NEP activity in RCC including papillary type as well as neighboring uninvolved kidney. A cross-sectional study was conducted in 57 patients undergoing radical nephrectomy and diagnosed with RCC. NEP activity, levels and expression were determined using flourogenic substrate, western blot and qPCR respectively in freshly-frozen tissues. Immunohistochemical analyses were also performed. Neuronal and non-neuronal levels of CGRP, SP and VIP levels were determined using two-step acetic acid extraction. Levels and activity of NEP were markedly decreased in RCC regardless of subtype. Similar levels of VIP were detected in first and second extractions. VIP levels were higher in clear cell and papillary RCC compared to nearby kidney tissue. VIP levels of neighboring kidney tissue of papillary type RCC was significantly lower compared to kidney samples from clear cell RCC. CGRP levels were higher in second extraction. Similar to VIP levels, CGRP levels of neighboring kidney tissue from clear cell and chromophobe type RCC was significantly lower compared to corresponding tumor samples, an effect observed in the second extraction. VIP and CGRP levels of nearby kidney tissue varied subtype dependently demonstrating that different subtypes of RCC alter their local environment differently. Furthermore NEP-induce hydrolysis of VIP creates selective VPAC-1 receptor agonist which has anti-proliferative and anti-inflammatory effects. Hence loss of NEP activity may prevent anti-tumoral effects of VIP on RCC.
Cancer Microenvironment – Springer Journals
Published: Oct 19, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.